|
Market Closed -
OTC Markets
19:19:26 28/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0306 USD | -19.26% |
|
-.--% | -90.47% |
| 09-17 | Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma | FI |
| 09-15 | Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says | MT |
Chart: Technical Analysis
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IMM | Delayed | |
OTC Markets
| PRRUF | Delayed | |
|
Deutsche Boerse AG
| YP1B | Delayed | |
|
Tradegate
| YP1B | Real-time | |
|
Börse Stuttgart
| YP1B | Delayed | |
|
Boerse Muenchen
| YP1B | Real-time | |
Nasdaq
| IMMP | Delayed | |
|
CBOE
| IMMP | Real-time | |
|
Tradegate
| YP1 | Real-time | |
|
Deutsche Boerse AG
| YP1 | Delayed | |
|
Börse Stuttgart
| YP1 | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IMM Stock
- PRRUF Stock
- Charts Immutep Limited
Select your edition
All financial news and data tailored to specific country editions
